Scarica l'app Stockscreener
30.79
0.06%
0.02
Dopo l'orario di chiusura:
30.79
Precedente Chiudi:
$30.77
Aprire:
$30.75
Volume 24 ore:
944.90K
Relative Volume:
0.66
Capitalizzazione di mercato:
$4.00B
Reddito:
-
Utile/perdita netta:
$-507.65M
Rapporto P/E:
-6.6935
EPS:
-4.6
Flusso di cassa netto:
$-616.24M
1 W Prestazione:
-4.65%
1M Prestazione:
-11.22%
6M Prestazione:
-58.52%
1 anno Prestazione:
-61.16%
Intervallo 1D:
$30.32
$31.18
Intervallo di 1 settimana:
$29.87
$32.32
Portata 52W:
$27.66
$121.06
Vaxcyte Inc Stock (PCVX) Company Profile
Nome
Vaxcyte Inc
Settore
Industria
Telefono
650-837-0111
Indirizzo
825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA
Confronta PCVX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PCVX
Vaxcyte Inc
|
30.79 | 3.99B | 0 | -507.65M | -616.24M | -4.60 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Vaxcyte Inc Stock (PCVX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-22 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-12-20 | Iniziato | Goldman | Buy |
| 2023-12-07 | Iniziato | Mizuho | Buy |
| 2023-04-18 | Iniziato | TD Cowen | Outperform |
| 2023-01-03 | Reiterato | Needham | Buy |
| 2022-12-15 | Iniziato | Guggenheim | Buy |
| 2022-11-17 | Iniziato | BTIG Research | Buy |
| 2021-12-29 | Ripresa | Jefferies | Buy |
| 2021-06-24 | Ripresa | Jefferies | Buy |
| 2020-07-07 | Iniziato | BofA Securities | Buy |
| 2020-07-07 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-07-07 | Iniziato | Needham | Buy |
Mostra tutto
Vaxcyte Inc Borsa (PCVX) Ultime notizie
Momentum Shift: What are Vaxcyte Inc.’s recent SEC filings showing2025 Big Picture & Low Drawdown Trading Strategies - خودرو بانک
Evaluating Vaxcyte Inc. with trendline analysisWeekly Market Outlook & Daily Volume Surge Trade Alerts - Newser
How to build a custom watchlist for Vaxcyte Inc.2025 Short Interest & Fast Moving Trade Plans - Newser
Advanced analytics toolkit walkthrough for Vaxcyte Inc.2025 Bull vs Bear & Comprehensive Market Scan Reports - Newser
Vaxcyte Inc. stock trend forecastIndex Update & AI Driven Price Forecasts - Newser
Can Vaxcyte Inc. Regain Lost Ground This Quarter getLinesFromResByArray error: size == 0 - kangso.co.kr
How institutional ownership impacts Vaxcyte Inc. stockEarnings Recap Summary & Risk Managed Investment Entry Signals - Newser
How to interpret RSI for Vaxcyte Inc. stockPortfolio Return Report & Detailed Earnings Play Alerts - Newser
How to forecast Vaxcyte Inc. trends using time seriesNew Guidance & Free Safe Entry Trade Signal Reports - Newser
Full technical analysis of Vaxcyte Inc. stock2025 Volatility Report & Technical Entry and Exit Tips - Newser
Is Vaxcyte Inc. stock reversal real or fakeMarket Sentiment Review & Precise Buy Zone Identification - Newser
Published on: 2025-08-31 17:30:01 - Newser
Multi factor analysis applied to Vaxcyte Inc.Market Activity Summary & Technical Entry and Exit Alerts - Newser
Risk vs reward if holding onto Vaxcyte Inc.July 2025 Levels & Stepwise Entry and Exit Trade Signals - Newser
Analyzing Vaxcyte Inc. with risk reward ratio chartsNew Guidance & Verified Momentum Stock Watchlist - Newser
Reversal indicators forming on Vaxcyte Inc. stockJuly 2025 Decliners & Reliable Momentum Entry Alerts - Newser
Is Vaxcyte Inc. forming a reversal patternJuly 2025 Intraday Action & AI Forecasted Entry and Exit Points - Newser
Using data models to predict Vaxcyte Inc. stock movementJuly 2025 News Drivers & Weekly Chart Analysis and Trade Guides - Newser
How to track smart money flows in Vaxcyte Inc.Exit Point & Consistent Return Investment Signals - Newser
Chart based analysis of Vaxcyte Inc. trendsQuarterly Profit Summary & Weekly High Conviction Ideas - Newser
How to manage a losing position in Vaxcyte Inc.Trade Risk Assessment & Precise Trade Entry Recommendations - Newser
Can technical indicators confirm Vaxcyte Inc.’s reversalWeekly Investment Report & Stock Portfolio Risk Management - Newser
Analyzing Vaxcyte Inc. with multi timeframe chartsPortfolio Value Summary & High Conviction Investment Ideas - Newser
What Fibonacci levels say about Vaxcyte Inc. rebound2025 Technical Overview & Advanced Technical Analysis Signals - Newser
How to recover losses in Vaxcyte Inc. stock2025 Breakouts & Breakdowns & Technical Pattern Based Signals - Newser
Vaxcyte Inc. Rebounds From Oversold Zone — Now What2025 Support & Resistance & AI Powered Buy/Sell Recommendations - sundaytimes.kr
Is Vaxcyte Inc. stock ready for a breakoutJuly 2025 Intraday Action & Community Trade Idea Sharing - Newser
Does Vaxcyte Inc. fit your quant trading model2025 Performance Recap & High Accuracy Trade Alerts - Newser
Does Vaxcyte Inc. qualify in momentum factor screening2025 Volume Leaders & Community Verified Watchlist Alerts - Newser
Vaxcyte Inc Azioni (PCVX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Vaxcyte Inc Azioni (PCVX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| GUGGENHIME ANDREW | PRESIDENT AND CFO |
Apr 07 '25 |
Option Exercise |
20.93 |
4,777 |
99,983 |
131,950 |
| PICKERING GRANT | CHIEF EXECUTIVE OFFICER |
Apr 04 '25 |
Option Exercise |
8.96 |
20,533 |
183,888 |
518,775 |
| Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC |
Mar 05 '25 |
Option Exercise |
21.41 |
5,000 |
107,050 |
46,620 |
| Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC |
Mar 05 '25 |
Sale |
70.74 |
5,000 |
353,699 |
41,620 |
0.96%
1.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):